Flu season no longer just means stocking up on tissues and chicken noodle soup. These days, every tickle in your throat or sudden chill comes with a double take: is it the flu—or could it be COVID-19?
For healthcare teams, the overlap in symptoms makes it tricky. The answers matter, because treatment timelines are short, and certainty is everything.
According to the CDC, the 2023–2024 U.S. flu season caused an estimated 40 million illnesses, 18 million medical visits, 470,000 hospitalizations, and 28,000 deaths. Add in the ongoing presence of COVID-19, which still drives tens of thousands of hospitalizations annually, and it’s clear: fast, accurate testing isn’t just convenient—it’s essential. Timely treatment is critical; the CDC notes flu antivirals are most effective within 48 hours of symptom onset.
The Quick-Draw Test Your Staff Can Trust
Developed by Wondfo USA, the makers of the trusted SAFElife™ toxicology line, the WELLlife™ COVID-19 & Influenza A&B Rapid Antigen Test (POC) is FDA-authorized under Emergency Use Authorization (EUA) for CLIA-waived clinical settings.
With a single nasal swab, the test differentiates between COVID-19, Influenza A, and Influenza B—delivering clear, visual results in just 10 minutes. That means you can test, read, and guide patients in a single visit without sending samples to an outside lab.
Key Features & Benefits
✔ Three results in one test – Separate lines for COVID-19, Flu A, and Flu B
✔ Fast & reliable – Results in ~10 minutes, with strong performance compared to PCR (COVID-19 Positive Percent Agreement 87.8%, Negative Percent Agreement 99.8%)
✔ Simple workflow – Swab, mix, drip, read—no specialized equipment required
✔ CLIA-waived – Authorized for use in professional and point-of-care settings
✔ Room-temperature storage – 2–30 °C (36–86 °F) for easy logistics
✔ Clear results – Distinct control (C) and test lines; even faint lines are valid
How It Works (4 Steps)
Swab – Collect an anterior nasal sample with the provided swab.
Mix – Stir the swab in the buffer solution and remove.
Drip – Add 4 drops into the cassette well.
Read – Check the result at 10 minutes (not before or after).
Full step-by-step instructions and result diagrams are available in the FDA Instructions for Use (PDF).
Who Uses This?
The WELLlife™ COVID-19 & Flu A&B Combo Test is built for real-world settings where speed and reliability matter most:
· Clinics & urgent-care centers: Rapidly determine whether patients have COVID-19, Flu A, or Flu B.
· Occupational health programs: Keep employees safe and on the job with quick, on-site screening.
· Schools & universities: Manage outbreaks quickly to protect students, teachers, and staff.
· Government agencies & community health programs: Scale testing for public health initiatives and rapid response.
· Healthcare providers: Get clear, immediate results to guide next steps—whether that’s prescribing antivirals, confirming with lab tests, or recommending isolation.
Safety & Compliance
✔ FDA EUA-authorized for use in CLIA-waived settings
✔ Presumptive negatives – Negative results should be confirmed with molecular testing if needed
✔ No subtype detection – The test differentiates COVID-19, Flu A, and Flu B, but not specific influenza subtypes or SARS-CoV-2 variants
The Bottom Line
When every cough, fever, or body ache could mean something different, the WELLlife™ COVID-19 & Flu A&B Combo Test helps you move from uncertainty to clarity in just 10 minutes.
At DrugScreens.com, we’re here to help you get the right tools, streamline your testing process, and keep your workplace, clinic, and community safe.
